Immune modulation by regulatory T-cells and macrophages

Immune modulation by regulatory T-cells (Tregs) and macrophages in the local microenvironment is a complex biological process characterized by the suppression of effector immune responses within a specific tissue site. In the context of the tumor microenvironment, Tregs utilize inhibitory receptors like CTLA-4 and secrete cytokines such as IL-10 and TGF-beta to dampen the activity of cytotoxic T-lymphocytes. Simultaneously, tumor-associated macrophages (TAMs), typically of the M2 phenotype, produce factors like arginase-1 and VEGF that further inhibit immune surveillance and promote angiogenesis and tissue repair. This coordinated activity creates a 'cold' or immune-excluded environment that allows for disease progression and resistance to standard therapies. Targeting this process involves a multi-pronged approach, including the use of checkpoint inhibitors, CSF1R antagonists to deplete suppressive macrophages, and agents that disrupt the metabolic or signaling pathways maintaining the suppressive state.

Other names

Treg and macrophage-mediated immunosuppressionTumor microenvironment immune modulationLocal immune suppressionImmune-suppressive microenvironment

Therapeutic modulation involves the depletion or functional inhibition of regulatory T-cells (Tregs) and the reprogramming of M2-polarized macrophages toward a pro-inflammatory M1 phenotype to restore anti-tumor or anti-pathogen immunity.